Sign In
Buy VCISY
$35.52
-0.0400 (-0.112%)
At Close: Jun 03, 2026
Vinci Compass Will Face A Challenging Period With Lower Liquidity (Downgrade)
07:38am, Saturday, 23'rd May 2026
Vinci Compass (VINP) is downgraded to Hold due to deteriorating earnings quality and shrinking core private equity operations. Headline FRE margin improvement is largely inorganic, driven by the Verde
VCISY Fairly Valued by DCF at $38
07:05am, Thursday, 14'th May 2026
On May 14, 2026, we delve into the DCF analysis for Vinci SA (VCISY), a company currently trading at $37.20. The stock has shown a mixed performance recently, w
Vinci Compass Investments Q1 Earnings Call Highlights
10:14pm, Monday, 11'th May 2026
Vinci Compass Investments NASDAQ: VINP reported record fee-related earnings for the first quarter of 2026, with management highlighting growth in assets under management, contributions from the Verde
Vinci Compass Announces Strategic Combination with BACS Asset Management to Build a Scaled Asset Management Platform in Argentina
05:00pm, Wednesday, 22'nd Apr 2026
Transaction doubles Vinci Compass' local Argentine asset management business, strengthens distribution through Banco Hipotecario and BACS, and positions the platform for accelerated growth in a rapi
Vinci SA (VCISY) Shareholder/Analyst Call Transcript
12:01pm, Tuesday, 14'th Apr 2026
Vinci SA (VCISY) Shareholder/Analyst Call Transcript
Realbotix Launches AI Vision System, Vinci, with Delivery of Ericsson Robot
07:30am, Wednesday, 08'th Apr 2026
LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading human-centric AI and humanoid robot manufacturer, has deliv
Vinci: There Are Better Value Infrastructure Plays Out There
03:21pm, Tuesday, 24'th Mar 2026
Vinci SA benefits from strong concessions performance and robust growth in its energy business, especially from electrification infrastructure trends. Airport concessions, notably in Japan and Budapes
Intuitive Surgical Poised for Growth in 2026 on da Vinci 5 Momentum
09:25am, Wednesday, 11'th Mar 2026
ISRG rides da Vinci 5 momentum as procedure volumes surge, global adoption expands and Ion and SP platforms boost recurring revenue growth into 2026.
Vinci SA (VCISY) Q4 2025 Earnings Call Transcript
07:44pm, Friday, 06'th Feb 2026
Vinci SA (VCISY) Q4 2025 Earnings Call Transcript
20 Million Patients Benefit from da Vinci Surgery Globally
09:15am, Friday, 23'rd Jan 2026
Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive's minimally invasive technologies Achievement reflects the dedication of
da Vinci 5 Expands Globally: Can ISRG Beat Overseas Cost Hurdles?
08:20am, Wednesday, 14'th Jan 2026
ISRG's da Vinci 5 begins international rollout, but pricing sensitivity, budgets, and reimbursement hurdles could slow adoption outside the United States.
Vinci (OTCMKTS:VCISY) Shares Gap Down – Should You Sell?
03:14am, Sunday, 11'th Jan 2026
Vinci SA (OTCMKTS:VCISY - Get Free Report) gapped down prior to trading on Friday. The stock had previously closed at $36.07, but opened at $35.22. Vinci shares last traded at $35.25, with a volume of
Can da Vinci 5 Expand Intuitive Surgical's TAM Beyond Core Surgeries?
10:20am, Friday, 09'th Jan 2026
ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory steps in general surgery.
Intuitive Surgical: Da Vinci Delivers, Double-Digit EPS Growth, Golden Cross
12:37pm, Tuesday, 02'nd Dec 2025
Intuitive Surgical delivered robust Q3 results, with 23% revenue growth and a significant double beat on EPS and revenue. ISRG's valuation remains lofty, trading near fair value despite strong growth
Vinci: Still Attractive Despite The Market Slide And Decline
04:54pm, Friday, 21'st Nov 2025
Vinci (VCISY) remains a 'BUY' for me, offering 15-19% annual upside and a 4%+ dividend yield. VCISY's diversified concession and construction portfolio, strong order book, and inflation-linked revenue
